Skip to main content

67 - References

References

Addictions and substance misuse CHAPTER 4 References

  1. UK Health Security Agency. UK Teratology Information Service. 2024; https://uktis.org.
  2. National Institute for Health and Care Excellence. Pregnancy and complex social factors: a model for service provision for pregnant women with complex social factors. Clinical guideline [CG110]. 2010 (last checked March 2024); https://www.nice.org.uk/guidance/CG110.
  3. World Health Organization. Guidelines for the Identification and Management of Substance Use and Substance Use Disorders in Pregnancy. Geneva: World Health Organization; 2014.
  4. Department of Health. Drug misuse and dependence: UK guidelines on clinical management. London: Department of Health. 2017; https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/673978/clinical_guidelines_2017.pdf.
  5. Popova S, et al. Fetal alcohol spectrum disorders. Nat Rev Dis Primers 2023; 9:11.
  6. Hudak ML, et al. Neonatal drug withdrawal. Pediatrics 2012; 129:e540–e560.
  7. Lingford-­Hughes AR, et al. Evidence-­based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. J Psychopharmacol 2012; 26:899–952.
  8. McAllister-­Williams RH, et  al. British Association for Psychopharmacology consensus guidance on the use of psychotropic medication ­preconception, in pregnancy and postpartum 2017. J Psychopharmacol 2017; 31:519–552.
  9. Kelty E, et  al. Pharmacotherapies for the treatment of alcohol use disorders during pregnancy: time to reconsider? Drugs 2021; 81:739–748.
  10. Haastrup MB, et al. Alcohol and breastfeeding. Basic Clin Pharmacol Toxicol 2014; 114:168–173.
  11. Royal College of Obstetricians and Gynaeocologists. Alcohol and pregnancy. 2018 (last accessed March 2024); https://www.rcog.org.uk/ for-­the-­public/browse-­our-­patient-­information/alcohol-­and-­pregnancy.
  12. Taylor L, et  al. Fetal safety of nicotine replacement therapy in pregnancy: systematic review and meta-­analysis. Addiction 2021; 116:239–277.
  13. National Institute for Health and Care Excellence. Tobacco: preventing uptake, promoting quitting and treating dependence. NICE guideline [NG209]. 2021 (last updated 2023, last accessed March 2024); https://www.nice.org.uk/guidance/ng209.
  14. Calder R, et al. Vaping in pregnancy: a systematic review. Nicotine Tob Res 2021; 23:1451–1458.
  15. Minozzi S, et al. Maintenance agonist treatments for opiate-­dependent pregnant women. Cochrane Database Syst Rev 2020; 11:CD006318.
  16. HalesMeds.com. Hale’s medications and mothers’ milk. 2024; https://www.halesmeds.com.
  17. Suarez EA, et al. First trimester use of buprenorphine or methadone and the risk of congenital malformations. JAMA Intern Med 2024; 184:242–251.
  18. Suarez EA, et al. Buprenorphine versus methadone for opioid use disorder in pregnancy. N Engl J Med 2022; 387:2033–2044.
  19. Degenhardt L, et al. Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-­analysis of randomised and observational studies. Lancet Psychiatry 2023; 10:386–402.
  20. Edge R, et al. Buprenorphine for Opioid Use Disorders during Pregnancy: a Review of Comparative Clinical Effectiveness, Safety, Cost-­ Effectiveness, and Guidelines. CADTH Rapid Response Reports. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2019.
  21. Link HM, et  al. Buprenorphine-­naloxone use in pregnancy: a systematic review and metaanalysis. Am J Obstet Gynecol MFM 2020; 2:100179.
  22. Ordean A, et al. Safety and efficacy of buprenorphine-­naloxone in pregnancy: a systematic review of the literature. Pathophysiology 2023; 30:27–36.
  23. Caritis SN, et al. An evidence-­based recommendation to increase the dosing frequency of buprenorphine during pregnancy. Am J Obstet Gynecol 2017; 217:459.e451–459.e456.
  24. Camurus Ltd. Buvidal in pregnancy and breastfeeding. Personal communication, 2024.
  25. Rausgaard NLK, et al. Management and monitoring of opioid use in pregnancy. Acta Obstet Gynecol Scand 2020; 99:7–15.
  26. Holmes AP, et  al. Breastfeeding considerations for mothers of infants with neonatal abstinence syndrome. Pharmacotherapy 2017; 37:861–869.
  27. Hayer S, et al. Cannabis and pregnancy: a review. Obstet Gynecol Surv 2023; 78:411–428.
  28. Shyken JM, et al. Benzodiazepines in pregnancy. Clin Obstet Gynecol 2019; 62:156–167.
  29. Wouldes TA, et al. Stimulants: how big is the problem and what are the effects of prenatal exposure? Semin Fetal Neonatal Med 2019; 24:155–160.

No comments to display

Back to top